[May 17, 2016]

Klebsiella Pneumoniae Infections Pipeline Report H1 2016 - Review of 21 Companies and their Drug Profiles - Research and Markets

Research and Markets has announced the addition of the "Klebsiella pneumoniae Infections - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Klebsiella Pneumoniae Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Klebsiella Pneumoniae Infections and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Klebsiella Pneumoniae Infectios Overview
3. Therapeutics Development
4. Pipeline Products for Klebsiella Pneumoniae Infections - Overview
5. Pipeline Products for Klebsiella Pneumoniae Infections - Comparative Analysis
6. Klebsiella Pneumoniae Infections - Therapeutics under Development by Companies
7. Klebsiella Pneumoniae Infections - Therapeutics under Investigation by Universities/Institutes
8. Klebsiella Pneumoniae Infections Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Klebsiella Pneumoniae Infections - Products under Development by Companies
13. Klebsiella Pneumoniae Infections - Products under Investigation by Universities/Institutes
14. Klebsiella Pneumoniae Infections - Companies Involved in Therapeutics Development

• Arsanis Biosciences GmbH
• Cellceutix Corporation
• Debiopharm International SA
• Evaxion Biotech ApS
• F. Hoffmann-La Roche Ltd.
• FOB Synthesis, Inc.
• Melinta Therapeutics, Inc
• Merck & Co., Inc.
• MicuRx Pharmaceuticals, Inc.
• Nosopharm SAS (News - Alert)
• Pfizer Inc.
• Phico Therapeutics Limited
• Procarta Biosystems Limited
• Sarepta Therapeutics, Inc.
• Shionogi & Co., Ltd.
• Soligenix, Inc.
• Sumitomo Dainippon Pharma Co., Ltd.
• Syntiron LLC
• Tetraphase Pharmaceuticals Inc.
• Theraclone Sciences, Inc.
• Varinel, Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160517006365/en/

[ Back To TMCnet.com's Homepage ]